Enflurane
General Anesthetic — NERVOUS SYSTEM
Also known as: (+/-)-Enflurane, efrane, ethrane, methylflurether
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Enflurane is an ofm drug in the General Anesthetic class catalogued in DrugCentral. It was first approved by the FDA in 1972. DrugCentral lists 6 molecular targets, including GLRA1, KCNK2 and KCNK3. Recorded indications include General anesthesia.
- Approval status: ofm (first approved 1972 by the FDA).
- Drug class: General Anesthetic.
- Molecular targets: GLRA1, KCNK2, KCNK3 and KCNK9 (6 listed in DrugCentral).
- Indications: General anesthesia.
- ATC code: N01AB04 (Halogenated hydrocarbons).
- Molecular formula: C3H2ClF5O; molecular weight 184.49 g/mol.
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Indications (1)
- General anesthesia
Contraindications (4)
- Duchenne muscular dystrophy
- Hyperkalemia
- Malignant hyperthermia
- Seizure disorder
Mechanism & targets
| Established pharmacologic class | General Anesthetic |
|---|
Molecular targets (6)
| Target | Gene | Action | Activity |
|---|---|---|---|
| Glycine receptor subunit alpha-1 | GLRA1 | other | — |
| Potassium channel subfamily K member 2 | KCNK2 | opener | — |
| Potassium channel subfamily K member 3 | KCNK3 | opener | — |
| Potassium channel subfamily K member 9 | KCNK9 | opener | — |
| Potassium channel subfamily K member 10 | KCNK10 | opener | — |
| Potassium channel subfamily K member 18 | KCNK18 | opener | — |
Regulatory approvals (1)
| Date | Agency | Marketed as | Applicant | Orphan |
|---|---|---|---|---|
| 1972-08-28 | FDA | — | BAXTER HLTHCARE |
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
N01AB04 | NERVOUS SYSTEM › ANESTHETICS › ANESTHETICS, GENERAL › Halogenated hydrocarbons |
Pharmacogenomics
Drug-label and guideline annotations from PharmGKB and CPIC.
- EMA label
Chemical structure
Full physicochemical, ADMET and 3D-structure analysis of Enflurane is on its molecule page.
| Molecular formula | C3H2ClF5O |
|---|---|
| Molecular weight | 184.49 g/mol |
| CAS number | — |
| InChIKey | JPGQOUSTVILISH-UHFFFAOYSA-N |
| PubChem CID | 3226 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is Enflurane used for?
DrugCentral lists the following indications for Enflurane: General anesthesia.
How does Enflurane work?
Its molecular targets in DrugCentral include GLRA1, KCNK2 (opener), KCNK3 (opener) and KCNK9 (opener).
When was Enflurane first approved?
Enflurane was first approved by the FDA in 1972.
What drug class does Enflurane belong to?
Enflurane is in the General Anesthetic class.
What is the chemical formula of Enflurane?
Enflurane has the molecular formula C3H2ClF5O and a molecular weight of 184.49 g/mol.
Browse: all drugs starting with E · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 1009 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL1257 — compound record and bioactivity
- PubChem CID 3226 — chemical identifiers
- DrugBank DB00228 — drug record
- FDA UNII 91I69L5AY5 — substance identity
- DailyMed: FDA labels for Enflurane — current prescribing information (label search)
- UniProt P23415 (GLRA1) — target protein
- UniProt O95069 (KCNK2) — target protein
- UniProt O14649 (KCNK3) — target protein
- UniProt Q9NPC2 (KCNK9) — target protein
- UniProt P57789 (KCNK10) — target protein
- UniProt Q7Z418 (KCNK18) — target protein
- PharmGKB / CPIC — pharmacogenomic label annotations
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.